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Abstract 
Immune cells coordinate their efforts for the correct and efficient functioning of the immune 
system (IS). Each cell type plays a distinct role and communicates with other cell types through 
mediators such as cytokines, chemokines and hormones, among others, that are crucial for the 
functioning of the IS and its fine tuning. Nevertheless, a quantitative analysis of the topological 
properties of an immunological network involving this complex interchange of mediators 
among immune cells is still lacking. Here we present a method for quantifying the relevance of 
different mediators in the immune network, which exploits a definition of centrality based on 
the concept of efficient communication. The analysis, applied to the human immune system, 
indicates that its mediators significantly differ in their network relevance. We found that 
cytokines involved in innate immunity and inflammation and some hormones rank highest in 
the network, revealing that the most prominent mediators of the IS are molecules involved in 
these ancestral types of defence mechanisms highly integrated with the adaptive immune 
response, and at the interplay among the nervous, the endocrine and the immune systems. 
 
Network analysis has emerged as a powerful approach to understanding complex 
phenomena and organization in social, technological and biological systems1-4. In 
particular it is increasingly recognized the role played by the topology of cellular 
networks, the intricate web of interactions among genes, proteins and other molecules 
regulating cell activity, in unveiling the function and the evolution of living organisms5-
9. The cells of the IS have various ways to communicate among each other: directly, by 
establishing bounds between cell surface ligands and receptors, and indirectly, by means 
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of a variety of soluble mediators released and bound by the immune cells10-11. Soluble 
mediators implement cellular communication both at short range (autocrine and 
paracrine cell stimulation) and across the major body systems (immune, endocrine and 
nervous systems). These mediators have a fundamental role in regulating the IS reaction 
to a possible danger, which triggers an integrated response involving both innate and 
clonotypic immunity, and which eventually results in an inflammatory response. 
Mediators are characterized by pleiotropy (each mediator has multiple targets) and 
redundancy (each mediator is produced by several sources), two characteristics that 
strongly influence the reliability of the IS, and that significantly contribute to its  
robustness and adaptability. From an experimental as well as theoretical point of view 
the main attention has been generally focussed on few limited subsets of immune cell 
types and mediators. Here we follow a different approach trying to grasp the global 
properties of the IS network, by modelling the whole system of immune cells as 
networked by soluble mediators. The network we consider is constituted by various 
immune cell types, which can act as both sources and targets of the exchanged 
mediators. The immune cell network is represented as a valued directed3 graph G, 
where the N cell types considered are the vertices of the graph and the M soluble 
mediators form its K arcs: a directed arc from vertex i to vertex j is defined by the 
existence of at least one mediator secreted by cell i and affecting cell j. Cell self-
stimulation by soluble mediators (autocriny), which is an important peculiarity of the 
immune cell network, is also taken into account. The value eij attached to the arc is 
assumed to be equal to the number of different mediators connecting the cell i to the cell 
j (Fig. 1). We consider such a number as a measure of the importance of the 
communication between two cells along the arc, hence modelling this as an efficiency12 
that measures the bandwidth. 
The IS is basically a parallel working system: all cells concurrently send 
information along the network through their outgoing arcs, i.e. by secreting mediators, 
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and receive information through their incoming arcs, i.e. by binding the mediators. Two 
cells/vertices in G can communicate through various paths, connecting them with 
different levels of efficiency: the efficiency of a path is the harmonic composition13 of 
the efficiencies of the component arcs. We assume that the communication between 
vertices i and j takes the most efficient path, and the efficiency of such path is indicated 
by εij 14. This approach represents an extension to valued networks of the shortest path 
assumption commonly used in social3, biological1,5-7 and 
communication/transportation1,2,12 networks. We characterize the system global 
properties by defining the network efficiency as12: 
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Network analysts have used centrality as a basic tool for identifying key 
individuals in a network3. A variety of  measures of centrality have been proposed over 
the years to quantify the topological importance of a node in a graph3,15. Differently, 
here we propose a method for quantifying the centrality of the various soluble mediators 
in the IS. The method is based on the concept of efficient communication over the 
immune cell network. The centrality of each mediator α (α = 1, ..., Μ) is measured by 
its network relevance rα , defined as the relative drop in the network efficiency E caused 
by the removal of the mediator, namely: 
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where Gα′  is the graph obtained by removing mediator α from G. In fact, in our 
framework, the removal of a mediator weakens some of the values eij attached to the 
arcs and, consequently, affects the communication between various couples of cells, 
decreasing some of the εij and thus the IS network efficiency. The method has been 
applied to human data retrieved by the Cytokine Reference Database16, taking into 
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account N=19  immune cell types (list in Fig.1) and M=93 soluble mediators (list in 
Fig. 3), selected among all available mediators as those connecting at least two different 
cell types from our immune cell list. The resulting graph G is dense, having N=19 
vertices and K=316 arcs (including self-connections) out of the 361 arcs of the full 
graph, and thus a pure topological analysis would be poorly significant. Therefore, we 
performed a more refined analysis by taking into account the strength of the interactions 
among the IS cells. The integer values eij attached to the arcs range from 1 to 36, since 
there are up to 36 different mediators connecting a couple of cells. In Fig. 2 we plot the 
cumulative relevance distribution defined as ( )( ) M rP r
M
= , where ( )M r
0.1
 is the number 
of mediators with relevance larger than r. For large values of the relevance,  shows 
a power-law behaviour with a scaling exponent 
( )P r
( 1)( )P r r γ− −≈ 2.8γ = ± . 
The fat-tail in the mediators relevance distribution indicates that the universal 
scaling principles discovered in other biological networks1,2,5,7 seem to be also 
fundamental ingredients of the human IS architecture. This shows that the concept of 
importance is selective and radical: immune cells form a highly inhomogeneous 
network in which a few soluble mediators play a central role in mediating the 
interactions between the different cell types. 
The network relevance of each mediator is reported in Fig. 3. 
The plot shows that only 3 mediators, TGF-β, MIP-1-α and -β (grouped as one 
mediator16) and TNF-α have network relevance larger than 0.5; 11 mediators have 
network relevance in the range [0.2, 0.5]; and, the remaining 79 have network relevance 
in the range [0, 0.2]. The sum of the network relevance of the first three mediators 
accounts for the 20.4% of total mediators relevance, while those of the second and third 
groups account for 34.7% and 44.9%, respectively. The unequal role played by the 
mediators in the efficient coordination of the immune network can be quantified by 
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means of the Gini coefficient. The Gini coefficient g is a measure used in economics 
and ecology to describe size-wealth inequality in a population. It compares the Lorenz 
curve of a ranked empirical distribution, i.e. a curve that shows, for the bottom x% of 
individuals, the percentage y% of the total size which they have, with the line of perfect 
equality17. The coefficient g ranges from a minimum value of zero, when all individuals 
are equal, to a theoretical maximum value of 1 in a population in which every individual 
except one has a size of zero. The value we have found g=0.64 confirms the large skew 
of relevance. 
The three most important mediators are pro- and anti-inflammatory molecules, 
and are involved in the communication among a large number of cell types, respectively 
216, 224 and 120. The second group of mediators includes 9 pro- and anti-inflammatory 
cytokines/chemokines, one non-inflammatory cytokine (IL-7), and one neuro-endocrine 
hormone (VIP/PACAP). So, notwithstanding the fact that among all mediators taken 
into account those involved in the inflammatory process are only the 24%, the 86% 
(twelve out of the fourteen) top molecules are all inflammatory and they account for the 
50% of all inflammatory mediators. 
The analysis shows that mediators involved in innate immunity and inflammation 
have the most central role in the immune network. In the last decade, innate immunity 
and inflammation emerged as a central component of the capability of the immune 
system to sense “danger” signals and to start immune responses, in turn involving cells 
of adaptive immunity18,19. The importance of innate immunity and inflammation is 
reinforced by recent data indicating that survival at extreme ages, and conversely 
mortality caused by major age-associated diseases, are related to low or high level of 
inflammation (“inflamm-aging”)20-22, respectively. From this point of view it is 
challenging that several inflammatory mediators, that have been experimentally studied 
and found to have a major role in aging and/or longevity, such as TGF-β23, TNF-α24, 
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IL-1025, IFN-γ26, IL-627, MCP-128, are included in the first two groups of relevant 
mediators, while two inflammatory cytokines, such as IL-1α and IL-1β, which do not 
seem to play a relevant role in these phenomena29, appear in the group of lower rank 
mediators. Thus, mediators involved in innate immunity - the most ancestral branch of 
the immune system - and in highly conserved defence pathways such as inflammation, 
appears to give a substantial contribution to the efficient communication of the IS 
network. Finally, the presence of a neuro-endocrine hormone, ranking high in the list of 
immune network mediators, suggests that further investigations with a set of cells and 
mediators including those from the neural and the endocrine systems, can shed light on 
the likely close interplay among these three systems30. 
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Figure 1. Portion of the immune cell network considered. In the figure a network 
with only four cell types out of the 19 considered, is illustrated. Cell types are 
the vertices of the graph, while diffusible mediators, which enable the cells to 
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communicate each other, define the arcs of the graph. Autocriny is also 
considered and depicted in the figure. The arcs are shown in three different 
colours for image benefit. The value ei,j associated to each arc is equal to the 
number of different mediators connecting cell i to the cell j. The name of the 
mediators are listed close to the respective arcs. The 19 cell types considered 
in the network are: B lymphocytes, basophils, dendritic cells, endothelial cells, 
eosinophils, epithelial cells, fibroblasts, granulocytes, macrophages, mast cells, 
monocytes, neutrophils, NK cells, spleen cells, stromal bone marrow cells, T 
lymphocytes, T CD4+ lymphocytes, T CD8+ lymphocytes, thymocytes. 
(Legend for Figure 1. B: B lymphocytes; D: Dendritic cell; G: Granulocyte; M: 
Mast cell; MΦ: Macrophage) 
 
Figure 2. Distribution of the number of mediators having a network relevance 
larger than r. The relevance of a mediator is calculated as the relative drop in 
network efficiency caused by its removal from the network. To reduce noise, 
logarithm binning was applied5. The linear tail in the figure indicates a scale-free 
power-law behaviour in the relevance of the various mediators of the immune 
cell network that can be fitted with a curve P(r) ≅ r -(γ-1) with γ = 2.8 ± 0.1. 
 
10 
 
Figure 3. Network relevance r of the mediators of the immune cell network. 
Mediators are ranked on the basis of their r value, where values are normalized 
so that the maximum value is set to 1. The fourteen mediators in the highest 
ranks, i.e. those that play a crucial role for the network efficient communication, 
are all pro- or anti-inflammatory mediators, except IL-7 (a T cell growth factor) 
and VIP/PACAP (an immuno-neuro-endocrine mediator). 
